Kennedy Capital Management, Inc. United Therapeutics Corp Transaction History

Kennedy Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$101.4 - $128.73 $2.31 Million - $2.93 Million	-22,796 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $1,251 - $1,424	-11 Reduced 0.05%	22,796 $2.92 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $221,092 - $258,625	2,186 Added 10.6%	22,807 $2.58 Million
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $466,149 - $660,635	-4,348 Reduced 17.41%	20,621 $2.32 Million
Q4 2017 Feb 13, 2018	SELL	$118.58 - $151.28 $329,889 - $420,860	-2,782 Reduced 10.02%	24,969 $3.69 Million
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $3.18 Million - $3.8 Million	27,751	27,751 $3.25 Million

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.